Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M6HE
|
|||
| Former ID |
DIB014692
|
|||
| Drug Name |
Simplirix
|
|||
| Synonyms |
GD2t; GD2-AS04; GSK-208141; HSV vaccine, SmithKline Beecham; Herpes virus subunit vaccine, GlaxoSmithKline; Herpesvirus subunit vaccine, SB; MPL herpes vaccine, GSK; GD2 subunit herpes vaccine + MPL, SmithKline Beecham; GD2 subunit herpes vaccine + SBAS4, GlaxoSmithKline; GD2 subunit herpes vaccine + SBAS4, SmithKline Beecham; HSV vaccine (1), GlaxoSmithKline
Click to Show/Hide
|
|||
| Indication | Genital herpes [ICD-11: 1A94; ICD-10: A60, A60.9] | Phase 3 | [1] | |
| Company |
GlaxoSmithKline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00698568) Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.